Skip to content
  • Tuesday, 30 June 2026
  • 5:03 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Bayer Acquires Perfuse Therapeutics for Up to $2.45 Billion to Bolster Ophthalmology Pipeline with Novel Endothelin Receptor Antagonist
Pharmaceutical R&D

Bayer Acquires Perfuse Therapeutics for Up to $2.45 Billion to Bolster Ophthalmology Pipeline with Novel Endothelin Receptor Antagonist

Teuku Ryan May 6, 2026 0

Bayer AG is set to significantly expand its presence in the ophthalmology market with the acquisition of Perfuse Therapeutics, a…

Read More
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Can live cell dynamics fix drug discovery’s efficacy problem?MIT scientists finally reveal the hidden structure of a mysterious high-tech materialThe Jovian System’s Icy Moons May Have Received the Building Blocks of Life from Their Nascent Environment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in SpermPens to pills: what oral GLP-1s change at the benchArc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s DiseaseTalawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
Dwi Wanna Jun 30, 2026
Laboratory Automation & Robotics
Pens to pills: what oral GLP-1s change at the bench
Lana Keisha Jun 30, 2026
Neuroscience & Brain Research
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
Rifan Muazin Jun 30, 2026
Pharmaceutical R&D
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ